-
1
-
-
66249108601
-
Understanding the Warburg effect: the metabolic requirements of cell proliferation
-
Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009; 324:1029–33
-
(2009)
Science
, vol.324
, pp. 1029-1033
-
-
Vander Heiden, M.G.1
Cantley, L.C.2
Thompson, C.B.3
-
2
-
-
70350743151
-
18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization
-
Jadvar H, Alavi A, Gambhir SS. 18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization. J Nucl Med 2009; 50:1820–7.
-
(2009)
J Nucl Med
, vol.50
, pp. 1820-1827
-
-
Jadvar, H.1
Alavi, A.2
Gambhir, S.S.3
-
3
-
-
35448940364
-
Adaptive landscapes and emergent phenotypes: why do cancers have high glycolysis?
-
Gillies RJ, Gatenby RA. Adaptive landscapes and emergent phenotypes: why do cancers have high glycolysis? J Bioenerg Biomembr 2007; 39:251–7.
-
(2007)
J Bioenerg Biomembr
, vol.39
, pp. 251-257
-
-
Gillies, R.J.1
Gatenby, R.A.2
-
4
-
-
33846417615
-
Metabolic changes during carcinogenesis: potential impact on invasiveness
-
Smallbone K, Gatenby RA, Gillies RJ, Maini PK, Gavaghan DJ. Metabolic changes during carcinogenesis: potential impact on invasiveness. J Theor Biol 2007; 244:703–13.
-
(2007)
J Theor Biol
, vol.244
, pp. 703-713
-
-
Smallbone, K.1
Gatenby, R.A.2
Gillies, R.J.3
Maini, P.K.4
Gavaghan, D.J.5
-
5
-
-
84858705550
-
Role of monocarboxylate transporters in human cancers: state of the art
-
Pinheiro C, Longatto-Filho A, Azevedo-Silva J, Casal M, Schmitt FC, Baltazar F. Role of monocarboxylate transporters in human cancers: state of the art. J Bioenerg Biomembr 2012; 44:127–39.
-
(2012)
J Bioenerg Biomembr
, vol.44
, pp. 127-139
-
-
Pinheiro, C.1
Longatto-Filho, A.2
Azevedo-Silva, J.3
Casal, M.4
Schmitt, F.C.5
Baltazar, F.6
-
7
-
-
84905096091
-
Extracellular acidity, a “reappreciated” trait of tumor environment driving malignancy: perspectives in diagnosis and therapy
-
Peppicelli S, Bianchini F, Calorini L. Extracellular acidity, a “reappreciated” trait of tumor environment driving malignancy: perspectives in diagnosis and therapy. Cancer Metastasis Rev 2014; 33:823–32.
-
(2014)
Cancer Metastasis Rev
, vol.33
, pp. 823-832
-
-
Peppicelli, S.1
Bianchini, F.2
Calorini, L.3
-
8
-
-
84883182637
-
Disrupting proton dynamics and energy metabolism for cancer therapy
-
Parks SK, Chiche J, Pouysségur J. Disrupting proton dynamics and energy metabolism for cancer therapy. Nat Rev Cancer 2013; 13:611–23.
-
(2013)
Nat Rev Cancer
, vol.13
, pp. 611-623
-
-
Parks, S.K.1
Chiche, J.2
Pouysségur, J.3
-
9
-
-
33646917296
-
The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism
-
Ullah MS, Davies AJ, Halestrap AP. The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism. J Biol Chem 2006; 281:9030–7.
-
(2006)
J Biol Chem
, vol.281
, pp. 9030-9037
-
-
Ullah, M.S.1
Davies, A.J.2
Halestrap, A.P.3
-
10
-
-
58249094845
-
Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH
-
Chiche J, Ilc K, Laferrière J, Trottier E, Dayan F, Mazure NM, Brahimi-Horn MC, Pouysségur J. Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH. Cancer Res 2009; 69:358–68.
-
(2009)
Cancer Res
, vol.69
, pp. 358-368
-
-
Chiche, J.1
Ilc, K.2
Laferrière, J.3
Trottier, E.4
Dayan, F.5
Mazure, N.M.6
Brahimi-Horn, M.C.7
Pouysségur, J.8
-
11
-
-
78649277216
-
Clinical utility of level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1
-
Schmitt M, Mengele K, Napieralski R, Magdolen V, Reuning U, Gkazepis A, Sweep F, Brünner N, Foekens J, Harbeck N. Clinical utility of level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1. Expert Rev Mol Diagn 2010; 10:1051–67.
-
(2010)
Expert Rev Mol Diagn
, vol.10
, pp. 1051-1067
-
-
Schmitt, M.1
Mengele, K.2
Napieralski, R.3
Magdolen, V.4
Reuning, U.5
Gkazepis, A.6
Sweep, F.7
Brünner, N.8
Foekens, J.9
Harbeck, N.10
-
12
-
-
78649269236
-
Characteristics of the level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1
-
Mengele K, Napieralski R, Magdolen V, Reuning U, Gkazepis A, Sweep F, Brünner N, Foekens J, Harbeck N, Schmitt M. Characteristics of the level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1. Expert Rev Mol Diagn 2010; 10:947–62.
-
(2010)
Expert Rev Mol Diagn
, vol.10
, pp. 947-962
-
-
Mengele, K.1
Napieralski, R.2
Magdolen, V.3
Reuning, U.4
Gkazepis, A.5
Sweep, F.6
Brünner, N.7
Foekens, J.8
Harbeck, N.9
Schmitt, M.10
-
13
-
-
0032079312
-
Hypoxia stimulates urokinase receptor expression through a heme protein-dependent pathway
-
Graham CH, Fitzpatrick TE, McCrae KR. Hypoxia stimulates urokinase receptor expression through a heme protein-dependent pathway. Blood 1998; 91:3300–7
-
(1998)
Blood
, vol.91
, pp. 3300-3307
-
-
Graham, C.H.1
Fitzpatrick, T.E.2
McCrae, K.R.3
-
14
-
-
0033521864
-
Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression
-
Graham CH, Forsdike J, Fitzgerald CJ, Macdonald-Goodfellow S. Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression. Int J Cancer 1999; 80:617–23
-
(1999)
Int J Cancer
, vol.80
, pp. 617-623
-
-
Graham, C.H.1
Forsdike, J.2
Fitzgerald, C.J.3
Macdonald-Goodfellow, S.4
-
15
-
-
0037374289
-
Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1
-
Krishnamachary B, Berg-Dixon S, Kelly B, Agani F, Feldser D, Ferreira G, Iyer N, LaRusch J, Pak B, Taghavi P, Semenza GL. Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res 2003; 63:1138–43
-
(2003)
Cancer Res
, vol.63
, pp. 1138-1143
-
-
Krishnamachary, B.1
Berg-Dixon, S.2
Kelly, B.3
Agani, F.4
Feldser, D.5
Ferreira, G.6
Iyer, N.7
LaRusch, J.8
Pak, B.9
Taghavi, P.10
Semenza, G.L.11
-
16
-
-
0037086083
-
Hypoxia promotes lymph node metastasis in human melanoma xenografts by up-regulating the urokinase-type plasminogen activator receptor
-
Rofstad EK, Rasmussen H, Galappathi K, Mathiesen B, Nilsen K, Graff BA. Hypoxia promotes lymph node metastasis in human melanoma xenografts by up-regulating the urokinase-type plasminogen activator receptor. Cancer Res 2002; 62:1847–53
-
(2002)
Cancer Res
, vol.62
, pp. 1847-1853
-
-
Rofstad, E.K.1
Rasmussen, H.2
Galappathi, K.3
Mathiesen, B.4
Nilsen, K.5
Graff, B.A.6
-
17
-
-
1642535600
-
Increased metastatic dissemination in human melanoma xenografts after sub-curative radiation treatment: radiation-induced increase in fraction of hypoxic cells and hypoxia-induced up-regulation of urokinase-type plasminogen activator receptor
-
Rofstad EK, Mathiesen B, Galappathi K. Increased metastatic dissemination in human melanoma xenografts after sub-curative radiation treatment: radiation-induced increase in fraction of hypoxic cells and hypoxia-induced up-regulation of urokinase-type plasminogen activator receptor. Cancer Res 2004; 64:13–8.
-
(2004)
Cancer Res
, vol.64
, pp. 13-18
-
-
Rofstad, E.K.1
Mathiesen, B.2
Galappathi, K.3
-
18
-
-
0030982781
-
Interaction of urokinase-type plasminogen activator with its receptor rapidly induces activation of glucose transporters
-
Anichini E, Zamperini A, Chevanne M, Caldini R, Pucci M, Fibbi G, Del Rosso M. Interaction of urokinase-type plasminogen activator with its receptor rapidly induces activation of glucose transporters. Biochemistry 1997; 36:3076–83.
-
(1997)
Biochemistry
, vol.36
, pp. 3076-3083
-
-
Anichini, E.1
Zamperini, A.2
Chevanne, M.3
Caldini, R.4
Pucci, M.5
Fibbi, G.6
Del Rosso, M.7
-
19
-
-
84937513716
-
Metabolic reprogramming supports the invasive phenotype in malignant melanoma
-
Bettum IJ, Gorad SS, Barkovskaya A, Pettersen S, Moestue SA, Vasiliauskaite K, Tenstad E, Øyjord T, Risa Ø, Nygaard V, Mælandsmo GM, Prasmickaite L. Metabolic reprogramming supports the invasive phenotype in malignant melanoma. Cancer Lett 2015; 366:71–83.
-
(2015)
Cancer Lett
, vol.366
, pp. 71-83
-
-
Bettum, I.J.1
Gorad, S.S.2
Barkovskaya, A.3
Pettersen, S.4
Moestue, S.A.5
Vasiliauskaite, K.6
Tenstad, E.7
Øyjord, T.8
Risa, Ø.9
Nygaard, V.10
Mælandsmo, G.M.11
Prasmickaite, L.12
-
20
-
-
58149172000
-
Apigenin inhibits the GLUT-1 glucose transporter and the phosphoinositide 3-kinase/Akt pathway in human pancreatic cancer cells
-
Melstrom LG, Salabat MR, Ding XZ, Milam BM, Strouch M, Pelling JC, Bentrem DJ. Apigenin inhibits the GLUT-1 glucose transporter and the phosphoinositide 3-kinase/Akt pathway in human pancreatic cancer cells. Pancreas 2008; 37:426–31.
-
(2008)
Pancreas
, vol.37
, pp. 426-431
-
-
Melstrom, L.G.1
Salabat, M.R.2
Ding, X.Z.3
Milam, B.M.4
Strouch, M.5
Pelling, J.C.6
Bentrem, D.J.7
-
21
-
-
80053421131
-
Endothelial progenitor cell-dependent angiogenesis requires localization of the full-length form of uPAR in caveolae
-
Margheri F, Chillà A, Laurenzana A, et al. Endothelial progenitor cell-dependent angiogenesis requires localization of the full-length form of uPAR in caveolae. Blood 2011; 118:3743–55.
-
(2011)
Blood
, vol.118
, pp. 3743-3755
-
-
Margheri, F.1
Chillà, A.2
Laurenzana, A.3
-
22
-
-
84904258144
-
The receptor for urokinase-plasminogen activator (uPAR) controls plasticity of cancer cell movement in mesenchymal and amoeboid migration style
-
Mar 30;
-
Margheri F, Luciani C, Taddei ML, et al. The receptor for urokinase-plasminogen activator (uPAR) controls plasticity of cancer cell movement in mesenchymal and amoeboid migration style. Oncotarget 2014 Mar 30; 5:1538–53.
-
(2014)
Oncotarget
, vol.5
, pp. 1538-1553
-
-
Margheri, F.1
Luciani, C.2
Taddei, M.L.3
-
23
-
-
84869069142
-
Cell surface remodeling by plasmin: a new function for an old enzyme
-
Deryugina EI, Quigley JP. Cell surface remodeling by plasmin: a new function for an old enzyme. J Biomed Biotechnol 2012; 2012:564259
-
(2012)
J Biomed Biotechnol
, vol.2012
, pp. 564259
-
-
Deryugina, E.I.1
Quigley, J.P.2
-
24
-
-
13844296556
-
Roles of the multifunctional glycoprotein, emmprin (basigin; CD147), in tumour progression
-
Yan L, Zucker S, Toole BP. Roles of the multifunctional glycoprotein, emmprin (basigin; CD147), in tumour progression. Thromb Haemost 2005; 93:199–204.
-
(2005)
Thromb Haemost
, vol.93
, pp. 199-204
-
-
Yan, L.1
Zucker, S.2
Toole, B.P.3
-
25
-
-
33745303045
-
Hypoxia signalling in cancer and approaches to enforce tumor regression
-
Pouyssegur J, Dayan F, Mazure NM. Hypoxia signalling in cancer and approaches to enforce tumor regression. Nature 2006; 441:437–43.
-
(2006)
Nature
, vol.441
, pp. 437-443
-
-
Pouyssegur, J.1
Dayan, F.2
Mazure, N.M.3
-
26
-
-
50149097983
-
Hyopxia, HIF1 and glucose metabolism in the solid tumor
-
Denko NC. Hyopxia, HIF1 and glucose metabolism in the solid tumor. Nat Rev Cancer 2008; 8:705–13.
-
(2008)
Nat Rev Cancer
, vol.8
, pp. 705-713
-
-
Denko, N.C.1
-
27
-
-
2942724235
-
mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways
-
Majumder PK, Febbo PG, Bikoff R, et al. mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways. Nat Med 2004; 10:594–601.
-
(2004)
Nat Med
, vol.10
, pp. 594-601
-
-
Majumder, P.K.1
Febbo, P.G.2
Bikoff, R.3
-
28
-
-
0142166332
-
Targeting HIF-1 for cancer therapy
-
Semenza GL. Targeting HIF-1 for cancer therapy. Nature Rev Cancer 2003; 3:721–32.
-
(2003)
Nature Rev Cancer
, vol.3
, pp. 721-732
-
-
Semenza, G.L.1
-
29
-
-
84931560018
-
Inhibition of uPAR-TGFβ crosstalk blocks MSC-dependent EMT in melanoma cells
-
Laurenzana A, Biagioni A, Bianchini F, Peppicelli S, Chillà A, Margheri F, Luciani C, Pimpinelli N, Del Rosso M, Calorini L, Fibbi G. Inhibition of uPAR-TGFβ crosstalk blocks MSC-dependent EMT in melanoma cells. J Mo lMed (Berl) 2015; 93:783–94.
-
(2015)
J Mo lMed (Berl)
, vol.93
, pp. 783-794
-
-
Laurenzana, A.1
Biagioni, A.2
Bianchini, F.3
Peppicelli, S.4
Chillà, A.5
Margheri, F.6
Luciani, C.7
Pimpinelli, N.8
Del Rosso, M.9
Calorini, L.10
Fibbi, G.11
-
30
-
-
40749163248
-
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
-
Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, Wei R, Fleming MD, Schreiber SL, Cantley LC. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 2008; 452:230–3.
-
(2008)
Nature
, vol.452
, pp. 230-233
-
-
Christofk, H.R.1
Vander Heiden, M.G.2
Harris, M.H.3
Ramanathan, A.4
Gerszten, R.E.5
Wei, R.6
Fleming, M.D.7
Schreiber, S.L.8
Cantley, L.C.9
-
31
-
-
78650801365
-
Downregulation of uPAR inhibits migration, invasion, proliferation, FAK/PI3K/Akt signaling and induces senescence in papillary thyroid carcinoma cells
-
Nowicki TS, Zhao H, Darzynkiewicz Z, Moscatello A, Shin E, Schantz S, Tiwari RK, Geliebter J. Downregulation of uPAR inhibits migration, invasion, proliferation, FAK/PI3K/Akt signaling and induces senescence in papillary thyroid carcinoma cells. Cell Cycle 2011; 10:100–7.
-
(2011)
Cell Cycle
, vol.10
, pp. 100-107
-
-
Nowicki, T.S.1
Zhao, H.2
Darzynkiewicz, Z.3
Moscatello, A.4
Shin, E.5
Schantz, S.6
Tiwari, R.K.7
Geliebter, J.8
-
34
-
-
18944401136
-
Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide
-
Llinas P, Le Du MH, Gardsvoll H, Dano K, Ploug M, Gilquin B, Stura EA, Ménez A. Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide. Embo J 2005; 24:1655–63.
-
(2005)
Embo J
, vol.24
, pp. 1655-1663
-
-
Llinas, P.1
Le Du, M.H.2
Gardsvoll, H.3
Dano, K.4
Ploug, M.5
Gilquin, B.6
Stura, E.A.7
Ménez, A.8
-
35
-
-
0032564309
-
Identification of specific sites involved in ligand binding by photoaffinity labeling of the receptor for the urokinase-type plasminogen activator. Residues located at equivalent positions in uPAR domains I and III participate in the assembly of a composite ligand-binding site
-
Ploug M. Identification of specific sites involved in ligand binding by photoaffinity labeling of the receptor for the urokinase-type plasminogen activator. Residues located at equivalent positions in uPAR domains I and III participate in the assembly of a composite ligand-binding site. Biochemistry 1998; 37:16494–505.
-
(1998)
Biochemistry
, vol.37
, pp. 16494-16505
-
-
Ploug, M.1
-
36
-
-
0346736507
-
The cleavage of the urokinase receptor regulates its multiple functions
-
Montuori N, Carriero MV, Salzano S, Rossi G, Ragno P. The cleavage of the urokinase receptor regulates its multiple functions. J Biol Chem 2002; 277:46932–9.
-
(2002)
J Biol Chem
, vol.277
, pp. 46932-46939
-
-
Montuori, N.1
Carriero, M.V.2
Salzano, S.3
Rossi, G.4
Ragno, P.5
-
37
-
-
80051702732
-
The urokinase receptor interactome
-
Eden G, Archinti M, Furlan F, Murphy R, Degryse B. The urokinase receptor interactome. Curr Pharm Des 2011; 17:1874–1889.
-
(2011)
Curr Pharm Des
, vol.17
, pp. 1874-1889
-
-
Eden, G.1
Archinti, M.2
Furlan, F.3
Murphy, R.4
Degryse, B.5
-
38
-
-
0025171582
-
Toxicity and effects of epidermal growth factor on glucose metabolism of MDA-468 human breast cancer cells
-
Kaplan O, Jaroszewski JW, Faustino PJ, Zugmaier G, Ennis BW, Lippman M, Cohen JS. Toxicity and effects of epidermal growth factor on glucose metabolism of MDA-468 human breast cancer cells. J Biol Chem 1990; 265:13641–9.
-
(1990)
J Biol Chem
, vol.265
, pp. 13641-13649
-
-
Kaplan, O.1
Jaroszewski, J.W.2
Faustino, P.J.3
Zugmaier, G.4
Ennis, B.W.5
Lippman, M.6
Cohen, J.S.7
-
39
-
-
84875459340
-
Proliferation-independent control of tumor glycolysis by PDGFR-mediated AKT activation
-
Ran C, Liu H, Hitoshi Y, Israel MA. Proliferation-independent control of tumor glycolysis by PDGFR-mediated AKT activation. Cancer Res 2013; 73:1831–43.
-
(2013)
Cancer Res
, vol.73
, pp. 1831-1843
-
-
Ran, C.1
Liu, H.2
Hitoshi, Y.3
Israel, M.A.4
-
40
-
-
0034814875
-
Increased IGFR activity and glucose transport in cultured skeletal muscle from insulin receptor null mice
-
Shefi-Friedman L, Wertheimer E, Shen S, Bak A, Accili D, Sampson SR. Increased IGFR activity and glucose transport in cultured skeletal muscle from insulin receptor null mice. Am J Physiol Endocrinol Metab 2001; 281:E16–24.
-
(2001)
Am J Physiol Endocrinol Metab
, vol.281
, pp. E16-24
-
-
Shefi-Friedman, L.1
Wertheimer, E.2
Shen, S.3
Bak, A.4
Accili, D.5
Sampson, S.R.6
-
41
-
-
46649121742
-
Hepatocyte growth factor is a novel stimulator of glucose uptake and metabolism in skeletal muscle cells
-
Perdomo G, Martinez-Brocca MA, Bhatt BA, Brown NF, O'Doherty RM, Garcia OA. Hepatocyte growth factor is a novel stimulator of glucose uptake and metabolism in skeletal muscle cells. J Biol Chem 2008; 283:13700–6.
-
(2008)
J Biol Chem
, vol.283
, pp. 13700-13706
-
-
Perdomo, G.1
Martinez-Brocca, M.A.2
Bhatt, B.A.3
Brown, N.F.4
O'Doherty, R.M.5
Garcia, O.A.6
-
42
-
-
0036596352
-
EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma
-
Liu D, Aguirre Ghiso JA, Estrada Y, Ossowski L. EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma. Cancer Cell 2002; 1:445–457.
-
(2002)
Cancer Cell
, vol.1
, pp. 445-457
-
-
Liu, D.1
Aguirre Ghiso, J.A.2
Estrada, Y.3
Ossowski, L.4
-
43
-
-
0037379794
-
ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK)
-
Aguirre-Ghiso JA, Estrada Y, Liu D, Ossowski L. ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK). Cancer Res 2003; 63:1684–95.
-
(2003)
Cancer Res
, vol.63
, pp. 1684-1695
-
-
Aguirre-Ghiso, J.A.1
Estrada, Y.2
Liu, D.3
Ossowski, L.4
-
44
-
-
84963625116
-
The role of Akt pathway signaling in glucose metabolism and metabolic oxidative stress
-
In, Spitz DR, Dornfeld KJ, Krishnan K, Gius D, eds., New York, Springer Science & Business Media
-
Simons AL, Orcutt KP, Madsen JM, Scarbrough PM, Spitz DR. The role of Akt pathway signaling in glucose metabolism and metabolic oxidative stress. In: Spitz DR, Dornfeld KJ, Krishnan K, Gius D, eds. Oxidative stress in cancer biology and therapy. New York: Springer Science & Business Media, 2012. 21–46.
-
(2012)
Oxidative stress in cancer biology and therapy
, pp. 21-46
-
-
Simons, A.L.1
Orcutt, K.P.2
Madsen, J.M.3
Scarbrough, P.M.4
Spitz, D.R.5
|